Nationwide Fund Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-47,741
| Closed | -$637K | – | 391 |
|
|
2017
Q3 | $637K | Hold |
47,741
| – | – | ﹤0.01% | 2055 |
|
|
2017
Q2 | $685K | Buy |
47,741
+13,759
| +40% | +$197K | ﹤0.01% | 2005 |
|
|
2017
Q1 | $719K | Buy |
33,982
+421
| +1% | +$8.91K | ﹤0.01% | 1948 |
|
|
2016
Q4 | $945K | Sell |
33,561
-3,270
| -9% | -$92.1K | ﹤0.01% | 1819 |
|
|
2016
Q3 | $986K | Buy |
36,831
+386
| +1% | +$10.3K | ﹤0.01% | 1799 |
|
|
2016
Q2 | $616K | Buy |
36,445
+21,713
| +147% | +$367K | ﹤0.01% | 2039 |
|
|
2016
Q1 | $328K | Sell |
14,732
-715
| -5% | -$15.9K | ﹤0.01% | 2301 |
|
|
2015
Q4 | $355K | Buy |
15,447
+215
| +1% | +$4.94K | ﹤0.01% | 2274 |
|
|
2015
Q3 | $305K | Hold |
15,232
| – | – | ﹤0.01% | 2363 |
|
|
2015
Q2 | $440K | Buy |
15,232
+10,236
| +205% | +$296K | ﹤0.01% | 2317 |
|
|
2015
Q1 | $153K | Buy |
4,996
+229
| +5% | +$7.01K | ﹤0.01% | 2823 |
|
|
2014
Q4 | $78K | Buy |
+4,767
| New | +$78K | ﹤0.01% | 2966 |
|